Inhibition of Notch3 prevents monocrotaline-induced pulmonary arterial hypertension

Experimental Lung Research
Yonghong ZhangManxiang Li

Abstract

It has been shown that activation of Notch3 signaling is involved in the development of pulmonary arterial hypertension (PAH) by stimulating pulmonary arteries remodeling, while the molecular mechanisms underlying this are still largely unknown. The aims of this study are to address these issues. Monocrotaline dramatically increased right ventricle systolic pressure to 39.0 ± 2.6 mmHg and right ventricle hypertrophy index to 53.4 ± 5.3% (P < 0.05 versus control) in rats, these were accompanied with significantly increased proliferation and reduced apoptosis of pulmonary vascular cells as well as pulmonary arteries remodeling. Treatment of PAH model with specific Notch inhibitor DAPT significantly reduced right ventricle systolic pressure to 26.6 ± 1.3 mmHg and right ventricle hypertrophy index to 33.5 ± 2.6% (P < 0.05 versus PAH), suppressed proliferation and enhanced apoptosis of pulmonary vascular cells as well as inhibited pulmonary arteries remodeling. Our results further indicated that level of Notch3 protein and NICD3 were increased in MCT-induced model of PAH, this was accompanied with elevation of Skp2 and Hes1 protein level and reduction of P27Kip1. Administration of rats with DAPT-prevented MCT induced these changes. ...Continue Reading

References

Apr 30, 1999·Science·S Artavanis-TsakonasR J Lake
Aug 14, 2003·Biochemical and Biophysical Research Communications·Wenli WangMatthew J Pollman
Jun 15, 2004·Journal of the American College of Cardiology·Marc HumbertMarlene Rabinovitch
May 5, 2005·Molecular and Cellular Biology·Kaoru MurataNagahiro Minato
Feb 21, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Lucio Miele
Nov 11, 2006·Journal of Cellular Physiology·Corinth A AuldRon F Morrison
Dec 2, 2006·Science·Matthias EhebauerAlfonso Martinez Arias
Jan 27, 2007·Cell·Isabel ChuJoyce Slingerland
Mar 21, 2008·Nature Reviews. Cancer·Isabel M ChuJoyce M Slingerland
Dec 17, 2008·Molecular and Cellular Biology·Arpita RayStacy W Blain
Oct 27, 2009·Nature Medicine·Xiaodong LiPatricia A Thistlethwaite
Dec 18, 2009·The FEBS Journal·Riaan ConradieJacky L Snoep
Mar 2, 2011·Expert Opinion on Therapeutic Targets·Adriana BorrielloFulvio Della Ragione
Apr 19, 2011·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Jia LiuXing Xie
Jun 22, 2011·Nature Reviews. Cardiology·Ralph T SchermulyFriedrich Grimminger
Dec 26, 2012·The Journal of Experimental Medicine·Jordi GuiuAnna Bigas
Sep 17, 2013·Seminars in Respiratory and Critical Care Medicine·Christophe Guignabert, Peter Dorfmuller
Sep 28, 2013·Arteriosclerosis, Thrombosis, and Vascular Biology·Yongguang XiaoWei Wang
Dec 21, 2013·Journal of the American College of Cardiology·Marius M HoeperDavid B Badesch
Jun 18, 2014·Molecular Genetics & Genomic Medicine·Ayako ChidaToshio Nakanishi
Aug 21, 2014·Journal of Gastrointestinal Cancer·Shaghayegh TalebMohammad Mahdi Forghanifard
Sep 6, 2014·Acta Neuropathologica Communications·Jessica KastChristof Haffner

❮ Previous
Next ❯

Citations

Mar 16, 2016·Medical Science Monitor Basic Research·Shaojun LiManxiang Li
Dec 24, 2019·Clinical Science·Hannah E MorrisRhian M Touyz
Jul 24, 2021·American Journal of Physiology. Heart and Circulatory Physiology·Sanghamitra SahooPatrick J Pagano

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis